Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemCollect is a specialized biotechnology company focused on the collection and cryopreservation of dental pulp stem cells (DPSCs). Based in the United Kingdom, the company provides a non-invasive service for harvesting high-quality mesenchymal stem cells from naturally shedding milk teeth and extracted wisdom teeth. These cells are processed in GMP-compliant facilities and stored in cryogenic conditions to ensure their long-term viability for potential future use in regenerative medicine. StemCollect positions its services as a form of biological insurance, offering families a way to preserve potent stem cells that could be used to treat various conditions, including neurodegenerative diseases and tissue repair. The company operates a direct-to-consumer model and adheres to strict regulatory standards for tissue handling and storage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Collect.